PRO5 COMPARING PRODUCTIVITY LOSSES FROM TREATING ATYPICAL HEMOLYTIC UREMIC SYNDROME PATIENTS IN THE UNITED STATES WITH ECULIZUMAB OR RAVULIZUMAB IN AN INFUSION CLINIC OR AT HOME
Abstract
Authors
A. Levy P.G.F. Chen I. Tomazos
A. Levy P.G.F. Chen I. Tomazos
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now